SCHEMBL44925

SCHEMBL44925

O=C(O)c1cc([N+](=O)[O-])nn1-c1ncccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 2/20 0.37
PKM P14618 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
ALDH1A1 P00352 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HSP90AA1 P07900 1/20 0.37
OPRK1 P41145 1/20 0.37
MALT1 Q9UDY8 2/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CCR2 P41597 1/20 0.35
GRM5 P41594 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL44870 0.86 LMNA (0.40) HTTLMNAMEN1KMT2ARXFP1
SCHEMBL44926 0.82 TRPA1 (0.36) HTTLMNAMEN1KMT2ARXFP1
SCHEMBL29558300 0.81 MALT1 (0.40) HTTLMNASMN1; SMN2PKMALDH1A1
SCHEMBL384656 0.81 KMT2A (0.43) LMNAMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL958268 0.81 MALT1 (0.40) HTTLMNASMN1; SMN2PKMALDH1A1
SCHEMBL27917418 0.81 KMT2A (0.38) LMNAMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL27727923 0.80 MALT1 (0.39) LMNASMN1; SMN2PKMALDH1A1MALT1
SCHEMBL535475 0.79 DHODH (0.41) LMNASMN1; SMN2PKMMALT1
SCHEMBL950148 0.79 ALDH1A1 (0.43) LMNAMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL19086951 0.79 MALT1 (0.38) LMNASMN1; SMN2PKMALDH1A1MALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791139-B2 Anthranilic diamide derivatives BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
EP-2582688-A1 ANTHRANILIC ACID DIAMIDE DERIVATIVES Bayer Intellectual Property GmbH (DE) 2013-04-24 EP disclosed
CN-103068813-A Anthranilic acid diamide derivatives BAYER CROPSCIENCE AG 2013-04-24 CN disclosed
US-20120015980-A1 ANTHRANILIC DIAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2012-01-19 US disclosed
WO-2011157654-A1 ANTHRANILIC ACID DIAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2011-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015980-A1 ANTHRANILIC DIAMIDE DERIVATIVES DDT, QDPR, ANTXR2 HTT 2721/4885LMNA 3458/4885MEN1 1583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.